Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Redmond

Showing results (321-330 of 331) with videos related to

Pageof 34
Sort By:
Cancer|June 1, 1977
Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trialB Fisher, E Montague, C Redmond, et al.
Plos One|January 21, 2017
Cohort Randomised Controlled Trial of a Multifaceted Podiatry Intervention for the Prevention of Falls in Older People (The REFORM Trial)Sarah Cockayne, Joy Adamson, Arabella Clarke, et al.
Trials|January 28, 2023
Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocolLara S Chapman, Anthony C Redmond, Caroline A Flurey, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
Patients' perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working GroupLara S Chapman, Begonya Alcacer-Pitarch, John D Pauling, et al.
Annals of the Rheumatic Diseases|December 13, 2016
The EULAR points to consider for health professionals undertaking musculoskeletal ultrasound for rheumatic and musculoskeletal diseasesHeidi J Siddle, Peter Mandl, Daniel Aletaha, et al.
Seminars in Arthritis and Rheumatism|May 8, 2023
Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group sessionLara S Chapman, Jennifer Jones, Anthony C Redmond, et al.
The New England Journal of Medicine|July 2, 1981
Treatment of primary breast cancer with chemotherapy and tamoxifenB Fisher, C Redmond, A Brown, et al.
Seminars in Arthritis and Rheumatism|February 28, 2025
What outcomes are important to people with foot and ankle disorders in rheumatic and musculoskeletal diseases? An OMERACT qualitative interview study across four continentsLara S Chapman, Caroline A Flurey, Pamela Richards, et al.
Journal of the National Cancer Institute|November 6, 1996
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumorsB Fisher, J Dignam, J Bryant, et al.
Trials|March 30, 2017
An optimised patient information sheet did not significantly increase recruitment or retention in a falls prevention study: an embedded randomised recruitment trialSarah Cockayne, Caroline Fairhurst, Joy Adamson, et al.
Pageof 34

Showing results (321-330 of 331) with videos related to

Sort By:
Pageof 34
Cancer|June 1, 1977
Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trialB Fisher, E Montague, C Redmond, et al.
Plos One|January 21, 2017
Cohort Randomised Controlled Trial of a Multifaceted Podiatry Intervention for the Prevention of Falls in Older People (The REFORM Trial)Sarah Cockayne, Joy Adamson, Arabella Clarke, et al.
Trials|January 28, 2023
Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocolLara S Chapman, Anthony C Redmond, Caroline A Flurey, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
Patients' perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working GroupLara S Chapman, Begonya Alcacer-Pitarch, John D Pauling, et al.
Annals of the Rheumatic Diseases|December 13, 2016
The EULAR points to consider for health professionals undertaking musculoskeletal ultrasound for rheumatic and musculoskeletal diseasesHeidi J Siddle, Peter Mandl, Daniel Aletaha, et al.
Seminars in Arthritis and Rheumatism|May 8, 2023
Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group sessionLara S Chapman, Jennifer Jones, Anthony C Redmond, et al.
The New England Journal of Medicine|July 2, 1981
Treatment of primary breast cancer with chemotherapy and tamoxifenB Fisher, C Redmond, A Brown, et al.
Seminars in Arthritis and Rheumatism|February 28, 2025
What outcomes are important to people with foot and ankle disorders in rheumatic and musculoskeletal diseases? An OMERACT qualitative interview study across four continentsLara S Chapman, Caroline A Flurey, Pamela Richards, et al.
Journal of the National Cancer Institute|November 6, 1996
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumorsB Fisher, J Dignam, J Bryant, et al.
Trials|March 30, 2017
An optimised patient information sheet did not significantly increase recruitment or retention in a falls prevention study: an embedded randomised recruitment trialSarah Cockayne, Caroline Fairhurst, Joy Adamson, et al.
Pageof 34